4.7 Article

Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence

Related references

Note: Only part of the references are listed.
Review Oncology

Awakening the guardian of genome: reactivation of mutant p53

Akshay Binayke et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment

Elizabeth A. Lopes et al.

CURRENT MEDICINAL CHEMISTRY (2019)

Editorial Material Oncology

Restoration of conformation of mutant p53

J. A. Green et al.

ANNALS OF ONCOLOGY (2018)

Review Biotechnology & Applied Microbiology

When the guardian sleeps: Reactivation of the p53 pathway in cancer

Olaf Merkel et al.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2017)

Review Biochemistry & Molecular Biology

Putting p53 in Context

Edward R. Kastenhuber et al.

Article Multidisciplinary Sciences

Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts

Sunil C. Kaul et al.

PLOS ONE (2016)

Article Oncology

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

Patricia A. J. Muller et al.

CANCER CELL (2014)

Article Biochemistry & Molecular Biology

Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters

Jayne Loughery et al.

NUCLEIC ACIDS RESEARCH (2014)

Review Oncology

Unravelling mechanisms of p53-mediated tumour suppression

Kathryn T. Bieging et al.

NATURE REVIEWS CANCER (2014)

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

Review Cell Biology

p53 mutations in cancer

Patricia A. J. Muller et al.

NATURE CELL BIOLOGY (2013)

Article Biochemistry & Molecular Biology

Small molecule induced reactivation of mutant p53 in cancer cells

Xiangrui Liu et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Biochemistry & Molecular Biology

Effect of Y220C Mutation on p53 and Its Rescue Mechanism: A Computer Chemistry Approach

Shah Md Abdur Rauf et al.

PROTEIN JOURNAL (2013)

Article Biochemistry & Molecular Biology

Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy

W-J Lu et al.

CELL DEATH AND DIFFERENTIATION (2011)

Article Oncology

Role of p53 in Cell Death and Human Cancers

Toshinori Ozaki et al.

Cancers (2011)

Article Cell Biology

TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use

Magali Olivier et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)

Review Cell Biology

Transcriptional control of human p53-regulated genes

Todd Riley et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)

Article Multidisciplinary Sciences

Targeted rescue of a destabilized mutant of p53 by an in silico screened drug

Frank M. Boeckler et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Biochemistry & Molecular Biology

Structure-function-rescue: the diverse nature of common p53 cancer mutants

A. C. Joerger et al.

ONCOGENE (2007)

Article Multidisciplinary Sciences

Structural basis for understanding oncogenic p53 mutations and designing rescue drugs

Andreas C. Joerger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biochemistry & Molecular Biology

Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo

Harumi Shimizu et al.

BIOCHEMICAL JOURNAL (2006)

Article Pathology

Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model

C Walker et al.

AMERICAN JOURNAL OF PATHOLOGY (2006)

Review Chemistry, Multidisciplinary

The Amber biomolecular simulation programs

DA Case et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

How many mutant p53 molecules are needed to inactivate a tetramer?

WM Chan et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Review Oncology

Post-translational modification of p53 in tumorigenesis

AM Bode et al.

NATURE REVIEWS CANCER (2004)

Review Cell Biology

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

CL Brooks et al.

CURRENT OPINION IN CELL BIOLOGY (2003)

Article Multidisciplinary Sciences

A peptide that binds and stabilizes p53 core domain:: Chaperone strategy for rescue of oncogenic mutants

A Friedler et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Biochemistry & Molecular Biology

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

VJN Bykov et al.

NATURE MEDICINE (2002)

Article Oncology

An N-terminal region of mot-2 binds to p53 in vitro

SC Kaul et al.

NEOPLASIA (2001)